Prognostic Value of Stem Cell Related Markers

Baruch Padeh Medical Center

Status: Withdrawn

Conditions: Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01265225

10.CTIL

Details and patient eligibility

About

The goal of the investigators study is to identify a prognostic marker that will evaluate the probability of recurrence in patients with stage 0-II breast cancer following surgery to remove the tumor.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Ductal Carcinoma in Situ
• DCIS + Microinvasion stages 1 or 11 without positive lymph nodes

Exclusion criteria

• tumor specimen with higher than grade II
• BRACA 1 or BRACA 2 mutation
• Neoadjuvant chemotherapy